OIS ANTERIOR SEGMENT 2020

EVENT POSTPONED - STAY TUNED FOR NEW DATE

This Ophthalmology Innovation Summit unites over 600 Corporate, Clinical and Capital leaders to collaborate on the development and commercialization of innovative therapies for the anterior segment.

OIS ISRAEL 2020

JUNE 15, 2020 | TEL AVIV, ISRAEL

Ophthalmology Innovation Summit is proud to announce our first international meeting in the beautiful city of Tel Aviv, Israel.

 

OIS RETINA 2020

JULY 23, 2020 | SEATTLE, WA

This Ophthalmology Innovation Summit unites 300 Corporate, Clinical and Capital leaders to collaborate on the development and commercialization of innovative therapies for the posterior segment.

12TH ANNUAL OIS 2020

NOVEMBER 12, 2020 | LAS VEGAS, NV

The Ophthalmology Innovation Summit began in 2009 and now unites over 1,200 Corporate, Clinical and Capital leaders to collaborate on the development and commercialization of innovative drugs, devices and diagnostics to address unmet vision disorders.

The Ophthalmology Innovation Summits facilitate meaningful interactions and the exchange of information between clinical, capital and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.

LATEST NEWS

Keeping an "Eye on Innovation" Through News & Analysis

Verana eyes adding third registry

April 2 2020

Verana eyes adding third registry

The explosion of healthcare information technology has engendered a chaotic landscape of infinite terabytes of disparate but mutually relevant data segregated in infinite silos where ...
Adverum, Gene Therapy, and AMD

March 25 2020

Adverum, Gene Therapy, and AMD

Adverum, a company pioneering novel gene therapies for ocular diseases, believes a gene therapy treatment for wet age-related macular degeneration (AMD) can reduce treatment burden ...
CRISPR and inherited retinal disease

March 18 2020

CRISPR and inherited retinal disease

Once again the eye proved to be the pioneer target in a new gene therapy approach, with the use in February of an agent utilizing ...
OIS@SECO In The Books

March 11 2020

OIS@SECO In The Books

Last week we heard firsthand at OIS@SECO’s second annual event just what it means to be innovative in the field of optometry. Leading off the ...
9 Steps to Launching a Product

March 3 2020

9 Steps to Launching a Product

Editor's Note: The FDA just approved Allergan's Durysta (bimatoprost implant) 10 mcg for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension on ...
2020’s Potential Retina Milestones

February 26 2020

2020’s Potential Retina Milestones

As reports of intraocular inflammation and vasculitis have cast caution onto the uptake of the newest approved anti-VEGF drug, Novartis’ Beovu (brolucizumab), the quest to ...

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.